Feb 27, 2024 7:45 am EST Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
Feb 15, 2024 4:30 pm EST Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
Jan 3, 2024 4:15 pm EST Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
Dec 27, 2023 10:40 pm EST Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
Nov 3, 2023 8:00 am EDT Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
Oct 19, 2023 4:30 pm EDT Profound Medical to Release Third Quarter 2023 Financial Results on November 2 – Conference Call to Follow